-
- Posts: 6
- Joined: Sun Jun 19, 2011 2:16 am
2. If my reportable value is OOS, will the 3 analysts with 3 preps each be ok for retest? Each prep has 2 inj each. Is it ok if each prep is treated as 1 retest having a total 9 retests? Is it ok if I set the intra analyst to NMT 2% RSD for the injection replicates? And what would be better for the intra analyst preparation? I set the RSD to NMT 2% or the NMT 2% difference among the 3 preps?
The inter analyst requirement passed if the % difference among the 3 analysts is NMT 2%.
The original is an outlier if it is outside of calculated average ±3σ for the retest results.
3. Considering the above situation, will my retest be invalidated if I did not meet the criteria I have set above? What if there is no laboratory error or no obvious error in our part. What will happen in my retest data?
4. What If I have mix of fail and pass result in my retests? What will to do then? How will I report my result?
5. Is this OOS procedure can be used if I have aberrant result in my routine analysis?
6. We are testing lab and not manufacturer so we cannot investigate on the manufacturing part. Any references given are very much appreciated. Other OOS insights other than HPLC analysis are also welcome. Thanks
